SMTL ID : 4eqc.1

Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.01 Å

Oligo State

monomer

Ligands

1 x XR1: 6-[2-chloro-4-(1,3-thiazol-5-yl)phenyl]-8-ethyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one(Non-covalent)

XR1.1: 17 residues within 4Å: Chain A: V.40, A.53, I.54, R.55, E.71, I.72, M.75, V.98, M.100, E.101, Y.102, L.103, G.106, D.110, L.152, T.162, T.297 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.53, A:M.100, A:Y.102, A:L.152, A:L.152 Hydrogen bonds: A:R.55, A:L.103, A:L.103 Salt bridges: A:D.110 pi-Cation interactions: A:R.55

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: A.104, G.154, M.155 Ligand excluded by PLIP CL.3: 5 residues within 4Å: Chain A: G.38, M.57, N.58, Q.61, Q.62 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Licciulli, S. et al., FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas. J.Biol.Chem. (2013)

Release Date

2013-08-28

Peptides

Serine/threonine-protein kinase PAK 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PAK 1